A powerful regenerative triple blend combining GHK-Cu, BPC-157, and TB-500 for comprehensive tissue repair and skin rejuvenation.
The GLOW Blend combines three of the most potent regenerative peptides: GHK-Cu (gene expression and collagen), BPC-157 (tissue healing and angiogenesis), and TB-500 (systemic repair and actin regulation). Together they provide synergistic effects on skin quality, wound healing, and tissue regeneration.
Subcutaneous injection
Per prescriber guidance
Daily to 3x/week
“A powerful regenerative triple blend combining GHK-Cu, BPC-157, and TB-500 for comprehensive tissue repair and skin rejuvenation.”
GHK-Cu resets gene expression toward youthful patterns and stimulates collagen synthesis. BPC-157 promotes angiogenesis and activates growth hormone receptors. TB-500 regulates actin polymerization and promotes cell migration. The combination provides multi-pathway regenerative support.
Per prescriber guidance
Daily to 3x/week
6–12 weeks
Subcutaneous injection
Reconstitute per prescriber instructions. The high GHK-Cu concentration (50 mg) provides potent gene-regulatory and skin benefits alongside the healing effects of BPC-157 and TB-500.
Add 5 mL bacteriostatic water per prescriber instructions.
Lyophilized: refrigerate. Reconstituted: refrigerate and use within 30 days.
When sourcing GLOW Blend for research purposes, the following quality benchmarks should be verified before use.
>98% (verified by HPLC)
Must be provided by supplier
<0.1 EU/mg (prevents bacterial contamination)
Manufactured in cGMP-certified facility
Independent lab verification preferred
Lyophilized: refrigerate. Reconstituted: refrigerate and use within 30 days.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.
Multiple animal studies and/or early human trials. Reasonable confidence in mechanism, but human data is limited.
Peptides commonly used alongside Tesamorelin / Ipamorelin / MGF for synergistic effects.
A short-acting GHRH analog that produces physiological GH pulses when combined with a GHRP like Ipamorelin.
The most selective GHRP available, stimulating GH release with minimal cortisol or prolactin elevation.
Category
Status
Dose
Per prescriber guidance
Frequency
Daily to 3x/week
Cycle
6–12 weeks
Peptides
Protocols
Other Pages
Contact Us Today!
© 2026 Best Health IQ. All rights reserved.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many compounds described on this site are not approved by the FDA for human therapeutic use. Some are available only as compounded preparations or as materials sold for laboratory use, and several are on FDA's Category 2 list for significant safety risks. Nothing on this site constitutes medical advice or a recommendation to use any compound described.
